Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 25

1.

Effect of tetrabenazine on tics and sleep of Gilles de la Tourette's syndrome.

Jankovic J, Glaze DG, Frost JD Jr.

Neurology. 1984 May;34(5):688-92.

PMID:
6584743
2.

Tourette's syndrome and role of tetrabenazine: review and personal experience.

Porta M, Sassi M, Cavallazzi M, Fornari M, Brambilla A, Servello D.

Clin Drug Investig. 2008;28(7):443-59. Review.

PMID:
18544005
3.

Neuroanatomy of Gilles de la Tourette's syndrome. Possible midbrain involvement.

Devinsky O.

Arch Neurol. 1983 Aug;40(8):508-14. Review.

PMID:
6347142
4.

Cholinergic mechanisms in Gilles de la Tourette's syndrome.

Sandyk R.

Int J Neurosci. 1995 Mar;81(1-2):95-100. Review.

PMID:
7775075
5.

Eye signs and tic disorders: Gilles de la Tourette's syndrome.

Goetz CG.

J Am Optom Assoc. 1997 Nov;68(11):688-92. Review.

PMID:
9409103
6.

Gilles de la Tourette's syndrome.

Faridi K, Suchowersky O.

Can J Neurol Sci. 2003 Mar;30 Suppl 1:S64-71. Review.

PMID:
12691479
7.

Tetrabenazine for the treatment of hyperkinetic movement disorders: a review of the literature.

Chen JJ, Ondo WG, Dashtipour K, Swope DM.

Clin Ther. 2012 Jul;34(7):1487-504. doi: 10.1016/j.clinthera.2012.06.010. Epub 2012 Jun 28. Review.

PMID:
22749259
8.

Tic disorders in childhood (and beyond).

Leung AK, Fagan JE.

Postgrad Med. 1989 Jul;86(1):251-2, 257-61. Review.

PMID:
2662159
9.

[A study of pathogenesis and symptoms of Tourette's syndrome--mainly on the importance of "startle reflex" through Latah reaction].

Nishida H, Shinbo Y, Motomura H.

Seishin Shinkeigaku Zasshi. 1994;96(1):26-47. Review. Japanese.

PMID:
8190811
10.

Tourette's syndrome. Tics, jerks, and quirks.

Santos CC, Massey EW.

Postgrad Med. 1990 Feb 1;87(2):71-8. Review.

PMID:
2405378
11.

Pharmacological options for the treatment of Tourette's disorder.

Jiménez-Jiménez FJ, García-Ruiz PJ.

Drugs. 2001;61(15):2207-20. Review.

PMID:
11772131
12.

Behavioral and clinical profiles of Tourette's disease: a comprehensive overview.

Messiha FS, Carlson JC.

Brain Res Bull. 1983 Aug;11(2):195-204. Review.

PMID:
6414653
13.

Recognition and management of Tourette's syndrome and tic disorders.

Bagheri MM, Kerbeshian J, Burd L.

Am Fam Physician. 1999 Apr 15;59(8):2263-72, 2274. Review.

14.

[Gilles de la Tourette's syndrome: diagnosis, pathogenesis and treatment].

Tolosa Sarró E, Bayés Rusiñol A, Muñoz Yunta JA.

Med Clin (Barc). 1983 Apr 16;80(13):592-6. Review. Spanish. No abstract available.

PMID:
6134880
15.

Emerging drugs in Tourette syndrome.

Silay YS, Jankovic J.

Expert Opin Emerg Drugs. 2005 May;10(2):365-80. Review.

PMID:
15934872
16.

Tics in childhood.

Golden GS.

Pediatr Ann. 1983 Nov;12(11):821-4. Review.

PMID:
6359039
17.

Tetrabenazine.

Fasano A, Bentivoglio AR.

Expert Opin Pharmacother. 2009 Dec;10(17):2883-96. doi: 10.1517/14656560903386292. Review.

PMID:
19929707
18.

Management of tics and Tourette's disorder: an update.

Bestha DP, Jeevarakshagan S, Madaan V.

Expert Opin Pharmacother. 2010 Aug;11(11):1813-22. doi: 10.1517/14656566.2010.486402. Review.

PMID:
20459362
19.

Recent advances in the management of tics.

Jankovic J.

Clin Neuropharmacol. 1986;9 Suppl 2:S100-10. Review. No abstract available.

PMID:
2885086
20.

Clinical pharmacology of nondopaminergic drugs in Tourette syndrome.

Hartmann A.

Int Rev Neurobiol. 2013;112:351-72. doi: 10.1016/B978-0-12-411546-0.00011-1. Review.

PMID:
24295626

Supplemental Content

Support Center